CD274 and neoplasm: Many TAAs or TEAs have been used to dock agonist the TNFRSF on tumor cells or cells present in the tumor microenvironment (TME); however, PDL1 is particularly interesting as its expression increases in tumor treated by oncolytic virus (Liu et al., 2017).